Document is current
Any future updates will be listed below
-
Authors
Gladman, Dafna D.
Nash, Peter
Mease, Philip J.
FitzGerald, Oliver
Duench, Stephanie
Cadatal, Mary Jane
Masri, Karim R.
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 3 July 2024
Accepted: 24 November 2024
First Online: 19 December 2024
Declarations
:
: Both studies were conducted in accordance with the Good Clinical Practice guidelines of the International Council for Harmonisation and with the principles of the Declaration of Helsinki. All patients provided written informed consent and the protocols were approved by the institutional review board or independent ethics committee at each investigational site.
: Not applicable.
: DDG has received grants and/or research support from AbbVie, Amgen, Celgene, Eli Lilly, Janssen, Novartis, Pfizer Inc, and UCB, and has acted as a consultant for AbbVie, Amgen, Bristol Myers Squibb, Celgene, Eli Lilly, Galapagos, Gilead Sciences, Janssen, Novartis, Pfizer Inc, and UCB. PN has received grants and/or research support from AbbVie, Bristol Myers Squibb, Celgene, Eli Lilly, Galapagos, GSK, Janssen, Novartis, Pfizer Inc, and UCB, and has received speaker fees/honoraria from AbbVie, Bristol Myers Squibb, Celgene, Eli Lilly, Galapagos, GSK, Janssen, Novartis, and Pfizer Inc. PJM has received grants and/or research support from AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eli Lilly, Galapagos, Gilead Sciences, Janssen, Novartis, Pfizer Inc, Sun, and UCB, has acted as a consultant for AbbVie, Acelyrin, Aclaris, Alumis, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Galapagos, Gilead Sciences, Inmagene, Janssen, MoonLake, Novartis, Pfizer Inc, Sun, UCB, and Ventyx, and has received speaker fees/honoraria from AbbVie, Amgen, Eli Lilly, Janssen, Novartis, Pfizer Inc, and UCB. OF has received grants and/or research support from AbbVie, Bristol Myers Squibb, Eli Lilly, Janssen, Novartis, Pfizer Inc, and UCB, has acted as a consultant for Bristol Myers Squibb, Celgene, Eli Lilly, Janssen, and Pfizer Inc, and has received speaker fees/honoraria from AbbVie, Janssen, Novartis, and Pfizer Inc. SD and MJC are employees and stockholders of Pfizer Inc. KRM is a stockholder of Pfizer Inc and was an employee of Pfizer Inc at the time of the analysis.
